Dapagliflozin
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5010 publications
Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.
Journal: American journal of therapeutics
Published: June 24, 2026
Correction: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK.
Journal: Cell & bioscience
Published: June 19, 2026
Can sodium-glucose cotransporter 2 (SGLT2) inhibition preserve renal structure and function in de novo kidney transplant recipients? Protocol for a randomised, double-blind, placebo-controlled trial assessing the efficacy of dapagliflozin on kidney structure, function and safety in kidney transplant recipients in Norway-the DEAK study.
Journal: BMJ open
Published: June 18, 2026
Rhodium-catalysed β-selective 1,4-addition of arylboron compounds to glycals enabled by chiral diene ligands.
Journal: Chemical communications (Cambridge, England)
Published: June 16, 2026
Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study.
Journal: BMC cardiovascular disorders
Published: June 03, 2026
Letter by Qin et al Regarding Article "Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure".
Journal: Circulation
Published: June 01, 2026
SGLT2 inhibitor dapagliflozin treats heart failure with preserved ejection fraction via the SIRT1/PGC-1α pathway.
Journal: Acta biochimica et biophysica Sinica
Published: May 29, 2026
Transcriptomics of S3 segment in mice: response to type 1 diabetes, SGLT1/2 inhibition, or GLP1 receptor agonism.
Journal: American journal of physiology. Renal physiology
Published: May 29, 2026
Palladium-Catalyzed Synthesis of S-Glycosides Via Stereoretentive Cross-Coupling.
Journal: Organic letters
Published: May 25, 2026
Alterations of Platelet MicroRNAs Associated With Dapagliflozin Treatment in Individuals With Type 2 Diabetes Mellitus.
Journal: Journal of cardiovascular pharmacology and therapeutics
Published: May 21, 2026
When Chronic Kidney Disease Therapies Meet the Allograft: Lessons From Dapagliflozin.
Journal: Transplantation
Published: May 21, 2026
Six-month effects of liraglutide and dapagliflozin on lipid profile, cardiovascular risk, and NT-proBNP levels in patients with metabolic dysfunction-associated steatotic liver disease.
Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)
Published: May 15, 2026
Last Updated: 06/30/2026